Endocuff-assisted Colonoscopy vs Standard Colonoscopy on Adenoma Detection Rate (Cuff-Bercy)

January 26, 2019 updated by: KARSENTI, Société Française d'Endoscopie Digestive

Endocuff-assisted Colonoscopy vs Standard Colonoscopy on Adenoma Detection Rate: A Comparative Prospective Study in Common Practice

This is a prospective study comparing endocuff-assisted colonoscopy to standard colonoscopy. The goal of this study is to evaluate the interest of second-generation Endocuff Vision (ECV) to improve Adenoma detection rate and / or Polyp detection rate as the Mean Number of Polyps (average number of polyps) in routine colonoscopy.

This is a prospective comparative study, on 2000 patients, 1000 in each group (with and without ECV)

Study Overview

Detailed Description

This is a prospective study comparing endocuff-assisted colonoscopy to standard colonoscopy. The goal of this study is to evaluate the interest of second-generation Endocuff Vision (ECV) to improve Adenoma detection rate and / or Polyp detection rate as the Mean Number of Polyps (average number of polyps) in routine colonoscopy.

Number of patients:

2000 patients, 1000 in each group (with and without ECV). To limit the risk of bias, the investigators will random two teams of 12 endoscopists matched in number, volume of activity and Adenoma Detection Rate (evaluated over a period of the year preceding the study).

Both periods of study will be approximately 3-4 months in length. In order to achieve a perfect balance between the two groups of patients, an inclusion tracking chart will be initiate and will be carefully controlled. Rebalancing will be done for both periods of study to obtain 500 patients per group and per period (= 2000 patients included).

Inclusion of 500 consecutive colonoscopies in each team of investigators, a "colonoscopy with ECV" team, a "colonoscopy without ECV" team then switch and inclusion of 500 new consecutive colonoscopies in each team, ie 2000 colonoscopies in total.

The selection of the team that will begin with ECV (Team A) and the team that will finish with ECV (Team B) will be chosen at random before the start of the study.

A comparison of the two colonoscopy groups with ECV vs without ECV will be made for each team (the investigator will be his own control) and then on the overall population after the end of the trial.

Study Type

Interventional

Enrollment (Actual)

2059

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Charenton-le-Pont, France, 94220
        • Clinique PARIS-BERCY

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patient scheduled for total colonoscopic exploration, during the period study
  2. Patient over or equal to 18 years
  3. ASA 1, ASA 2, ASA 3
  4. No participation in another clinical study
  5. Certificate of non opposition signed

Exclusion Criteria:

  1. Patient under 18 years old
  2. ASA 4, ASA 5
  3. Pregnant woman
  4. Patient with coagulation abnormalities preventing polypectomy: prothrombin level <50%, Platelets <50000 / mm3, effective anti-coagulation in progress, clopidogrel in progress.
  5. Inflammatory bowel disease
  6. Known colonic stenosis
  7. Diverticulitis less than 6 weeks old
  8. Patient unable to give consent or protected by law
  9. Opposition expressed for inclusion in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Colonoscopy with Endocuff Vision (ECV)
ECV-assisted colonoscopy ( with the use of Endocuff Vision (ECV) Second generation)
Colonoscopy performed with the use of "Endocuff Vision (ECV) second generation" at the tip of the scope
No Intervention: Standard colonoscopy
Standard colonoscopy (without the use of Endocuff Vision (ECV) Second generation)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adenoma detection rate (ADR)
Time Frame: during procedure
rate (%) of colonoscopies with one or more adenoma detected
during procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Polyp detection rate (PDR)
Time Frame: during procedure
rate (%) of colonoscopies with one or more polyp detected
during procedure
Advanced neoplasia detection rate (ANDR)
Time Frame: during procedure
rate (%) of colonoscopies with one or more advanced neoplasia detected
during procedure
Serrated polyp detection rate (SPDR)
Time Frame: during procedure
rate (%) of colonoscopies with one or more serrated polyp detected
during procedure
Morbidity: perforation rate (%)
Time Frame: 21 days after procedure
Perforation rates (%)
21 days after procedure
Morbidity: bleeding rate (%)
Time Frame: 21 days after procedure
Bleeding rates (%)
21 days after procedure
caecal intubation rate (%)
Time Frame: during procedure
caecal intubation rate (complete colonoscopy)
during procedure
Time to reach caecum (sec)
Time Frame: during procedure
Time to reach caecum from the beginning of the procedure (in seconds)
during procedure
withdrawal time (sec)
Time Frame: during procedure
withdrawal time of the scope from the caecum to the end of the procedure (in seconds)
during procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2017

Primary Completion (Actual)

November 15, 2018

Study Completion (Actual)

November 15, 2018

Study Registration Dates

First Submitted

November 12, 2017

First Submitted That Met QC Criteria

November 14, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

January 29, 2019

Last Update Submitted That Met QC Criteria

January 26, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonic Polyp

Clinical Trials on Endocuff Vision (ECV) second generation

3
Subscribe